News
Bitcoin Falls 2%, Slips to $93,684 on Market Jitters
New Delhi, India, November 17- Bitcoin fell nearly 2% on Sunday, closing at $93,684 as the cryptocurrency market showed signs of weakness. The world’s largest
Read MoreCategory: News
News
U.S. Data Backlog Looms While Cautious Trading Continues
The dollar stayed stable on Monday as traders waited for a large batch of delayed economic reports. Investors adopted a cautious tone because they believed
Read More
News
UK Reports Record AI Growth in Machine Learning Market
New Delhi, India, November 14- November 2025 proved a defining month for the machine learning (ML) market. Major government bodies in the UK and EU
Read More
News
FDA Grants Biosimilar Approval for HER2-Positive Breast Cancer
Pune, India | November 14, 2025 The U.S. Food and Drug Administration (FDA) approved Poherdy (pertuzumab-dpzb) as the inaugural interchangeable biosimilar to Perjeta (pertuzumab). This
Read More
News
UK-China Tech Collab Shift Cuts Satellites and Robotics Work
The United Kingdom has reshaped its scientific partnership with China through a refined UK-China Tech Collab, designed to limit exposure to sensitive technology. The government
Read More
News
Cloud Service Industry Gains Momentum Amid AI Adoption
New Delhi, India, November 13 – Global cloud service providers are stepping up their growth as demand for artificial intelligence and secure digital infrastructure surges.
Read More
News
AI Child Abuse Imagery in the UK Under Tougher AI Testing
The UK government is intensifying efforts to prevent AI child abuse imagery. Officials are developing stricter rules for testing AI systems that can generate visual
Read More
News
Data Center Chip Demand Fuels AMD’s Bold Profit Goals
New Delhi, India, November 12- Advanced Micro Devices (AMD) is setting ambitious targets for the next decade, projecting that its profits could triple by 2030
Read More
News
Measles Elimination Status Loss of Canada Alarms Health Experts
Canada’s health system once stood as a model of disease control. Today, it faces a sobering reality: the country has lost its Measles Elimination Status
Read More
News
Dupixent Demonstrates Significant Benefits for Atopic Dermatitis
Pune, India | November 11, 2025 Dupixent (dupilumab) achieved all primary and secondary endpoints in a pivotal phase 3 trial, offering hope for young children. The
Read More